Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric F Morand

Showing results (91-100 of 226) with videos related to

Pageof 23
Sort By:
The Lancet. Rheumatology|January 26, 2024
Utility of repeated antinuclear antibody tests: a retrospective database studyAi Li Yeo, Suong Le, Jason Ong, et al.
The Lancet. Rheumatology|January 27, 2024
Glucocorticoid gene signatures in systemic lupus erythematosus and the effects of type I interferon: a cross-sectional and in-vitro studyMelissa Northcott, Linden J Gearing, Hieu T Nim, et al.
Lupus Science & Medicine|June 18, 2020
Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosusFabien B Vincent, Rangi Kandane-Rathnayake, Rachel Koelmeyer, et al.
Lupus Science & Medicine|February 18, 2021
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trialsRaj Tummala, Gabriel Abreu, Lilia Pineda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus ErythematosusIna Rudloff, Jack Godsell, Claudia A Nold-Petry, et al.
Lupus Science & Medicine|February 28, 2023
Clinical associations of cognitive dysfunction in systemic lupus erythematosusSudha Raghunath, Yifat Glikmann-Johnston, Vera Golder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2010
Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion moleculesQiang Cheng, Sonja J McKeown, Leilani Santos, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2021
What Does It Mean to Be a British Isles Lupus Assessment Group-Based Composite Lupus Assessment Responder? Post Hoc Analysis of Two Phase III TrialsRichard Furie, Eric F Morand, Ian N Bruce, et al.
The American Journal of Pathology|September 11, 2010
Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: effects on glucocorticoid-induced MKP1Jennifer A Ralph, Afsar U Ahmed, Leilani L Santos, et al.
Frontiers in Immunology|August 6, 2019
Novel Methods of Incorporating Time in Longitudinal Multivariate Analysis Reveals Hidden Associations With Disease Activity in Systemic Lupus ErythematosusHieu T Nim, Kathryn Connelly, Fabien B Vincent, et al.
Pageof 23

Showing results (91-100 of 226) with videos related to

Sort By:
Pageof 23
The Lancet. Rheumatology|January 26, 2024
Utility of repeated antinuclear antibody tests: a retrospective database studyAi Li Yeo, Suong Le, Jason Ong, et al.
The Lancet. Rheumatology|January 27, 2024
Glucocorticoid gene signatures in systemic lupus erythematosus and the effects of type I interferon: a cross-sectional and in-vitro studyMelissa Northcott, Linden J Gearing, Hieu T Nim, et al.
Lupus Science & Medicine|June 18, 2020
Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosusFabien B Vincent, Rangi Kandane-Rathnayake, Rachel Koelmeyer, et al.
Lupus Science & Medicine|February 18, 2021
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trialsRaj Tummala, Gabriel Abreu, Lilia Pineda, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus ErythematosusIna Rudloff, Jack Godsell, Claudia A Nold-Petry, et al.
Lupus Science & Medicine|February 28, 2023
Clinical associations of cognitive dysfunction in systemic lupus erythematosusSudha Raghunath, Yifat Glikmann-Johnston, Vera Golder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2010
Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion moleculesQiang Cheng, Sonja J McKeown, Leilani Santos, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 29, 2021
What Does It Mean to Be a British Isles Lupus Assessment Group-Based Composite Lupus Assessment Responder? Post Hoc Analysis of Two Phase III TrialsRichard Furie, Eric F Morand, Ian N Bruce, et al.
The American Journal of Pathology|September 11, 2010
Identification of NURR1 as a mediator of MIF signaling during chronic arthritis: effects on glucocorticoid-induced MKP1Jennifer A Ralph, Afsar U Ahmed, Leilani L Santos, et al.
Frontiers in Immunology|August 6, 2019
Novel Methods of Incorporating Time in Longitudinal Multivariate Analysis Reveals Hidden Associations With Disease Activity in Systemic Lupus ErythematosusHieu T Nim, Kathryn Connelly, Fabien B Vincent, et al.
Pageof 23